Choose the brand aligned with your industry so we can best serve your needs.
For researchers, scientists, and technical professionals: Your one-stop shop for the complete range of laboratory, production, and safety products and services.
DRI-C21045 is a small-molecule inhibitor of the CD40-CD40L protein-protein interaction used in research to modulate immune costimulatory signaling. It is reported to be active at submicromolar concentrations (IC50 ≈ 0.17 μM) and is supplied as a solid research compound.
DRI-C21045 is a small-molecule inhibitor of the CD40-CD40L protein-protein interaction, supplied for research use with reported in vitro potency (IC50 ≈ 0.17 μM) and high purity suitable for biochemical and cell-based studies.
Potent inhibitor of the CD40-CD40L protein-protein interaction (reported IC50 ~0.17 μM).
High purity suitable for research (≈98.1%).
Molecular formula C32H24N2O7S and molecular weight 580.61 g/mol.
Available in small research pack sizes for in vitro studies.
Intended for biochemical and cell-based research; not for therapeutic use.
Encompass Procurement Services Non-distribution item offered as a customer accommodation; additional freight charges may apply. Learn More
The PD-L1 antibody [MSVA-711R] HistoMAX™ (GTX04362) is a Rabbit Monoclonal antibody in the GeneTex HistoMAX portfolio. The antibody is extensively evaluated for IHC-P using formalin-fixed human normal tissues (more than 70 different sections) and cancer tissue arrays to guarantee specificity and best-in-class performance. Information regarding both manual and autostainer staining protocols are available.Figure Legend: IHC-P analysis of human invasive breast cancer of no special type (NST) tissue using GTX04362 PD-L1 antibody [MSVA-711R] HistoMAX. Breast cancer NST with PD-L1 negative tumor cells but intense PD-L1 staining in tumor associated inflammatory cells.
Encompass Procurement Services Non-distribution item offered as a customer accommodation; additional freight charges may apply. Learn More
Traditional Kinetic Jaffé Traditional Kinetic Jaffé methods are subject to severe interference by both bilirubin and hemolysis because the absorbance of these substances changes progressively with time due to oxidation or "bleaching" during the reaction. Synermed VI360 Kinetic Jaffé The Synermed kinetic creatinine decolorizes both bilirubin and hemoglobin. The background absorbance is lower thereby simplifying the spectrophotometric measurement of absorbance change and eliminating negative interference due to loss of absorbance of chromatic substances. No Interference from Serum BilirubinNo Interference from Serum HemoglobinCompares to Expensive Enzymatic Methods
Encompass Procurement Services Non-distribution item offered as a customer accommodation; additional freight charges may apply. Learn More